{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:30:27Z","timestamp":1792287027635,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T00:00:00Z","timestamp":1461110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute of Postgraduate Medical Education and Research","doi-asserted-by":"crossref","award":["Edn.7(1)\/2013"],"award-info":[{"award-number":["Edn.7(1)\/2013"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00228-016-2061-x","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T06:57:58Z","timestamp":1461135478000},"page":"807-812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population"],"prefix":"10.1007","volume":"72","author":[{"given":"Manu","family":"Jose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanthi","family":"Mathaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivanand","family":"Kattimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendiran","family":"Adithan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithan","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"key":"2061_CR1","unstructured":"WHO | Global status report on alcohol and health 2011. In: WHO. http:\/\/www.who.int\/substance_abuse\/publications\/global_alcohol_report\/en\/ . Accessed 28 Nov 2015"},{"key":"2061_CR2","first-page":"1443","volume":"69","author":"M Bayard","year":"2004","unstructured":"Bayard M, McIntyre J, Hill KR, Woodside J Jr (2004) Alcohol withdrawal syndrome. Am Fam Physician 69:1443\u20131450","journal-title":"Am Fam Physician"},{"key":"2061_CR3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","volume":"84","author":"JT Sullivan","year":"1989","unstructured":"Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353\u20131357","journal-title":"Br J Addict"},{"key":"2061_CR4","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5","author":"Association AP","year":"2013","unstructured":"Association AP (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5, 5th edn. American Psychiatric Publishing, Washington","edition":"5"},{"key":"2061_CR5","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1530-0277.2006.00242.x","volume":"30","author":"UC Lutz","year":"2006","unstructured":"Lutz UC, Batra A, Kolb W, Machicao F, Maurer S, Kohnke MD (2006) Methylenetetrahydrofolate reductase C677T-polymorphism and its association with alcohol withdrawal seizure. Alcohol Clin Exp Res 30:1966\u20131971","journal-title":"Alcohol Clin Exp Res"},{"key":"2061_CR6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00008571-200111000-00002","volume":"11","author":"MJ Lucht","year":"2001","unstructured":"Lucht MJ, Kuehn KU, Schroeder W et al (2001) Influence of the dopamine D2 receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawal. Pharmacogenetics 11:647\u2013653","journal-title":"Pharmacogenetics"},{"key":"2061_CR7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0025-7125(05)70554-X","volume":"81","author":"R Saitz","year":"1997","unstructured":"Saitz R, O\u2019Malley SS (1997) Pharmacotherapies for alcohol abuse. Withdrawal and treatment. Med Clin North Am 81:881\u2013907","journal-title":"Med Clin North Am"},{"key":"2061_CR8","doi-asserted-by":"publisher","unstructured":"Amato L, Minozzi S, Vecchi S, Davoli M (2010) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev CD005063. doi: 10.1002\/14651858.CD005063.pub3","DOI":"10.1002\/14651858.CD005063.pub3"},{"key":"2061_CR9","first-page":"649","volume":"160","author":"AM Holbrook","year":"1999","unstructured":"Holbrook AM, Crowther R, Lotter A et al (1999) Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 160:649\u2013655","journal-title":"CMAJ"},{"key":"2061_CR10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/0976-500X.99440","volume":"3","author":"B Bharadwaj","year":"2012","unstructured":"Bharadwaj B, Bernard M, Kattimani S, Rajkumar RP (2012) Determinants of success of loading dose diazepam for alcohol withdrawal: a chart review. J Pharmacol Pharmacother 3:270\u2013272","journal-title":"J Pharmacol Pharmacother"},{"key":"2061_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03161171","volume":"2","author":"JB Hack","year":"2006","unstructured":"Hack JB, Hoffmann RS, Nelson LS (2006) Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2:55\u201360","journal-title":"J Med Toxicol"},{"key":"2061_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2125.1994.tb04336.x","volume":"38","author":"T Andersson","year":"1994","unstructured":"Andersson T, Miners JO, Veronese ME, Birkett DJ (1994) Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol 38:131\u2013137","journal-title":"Br J Clin Pharmacol"},{"key":"2061_CR13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2710.2007.00829.x","volume":"32","author":"T Fukasawa","year":"2007","unstructured":"Fukasawa T, Suzuki A, Otani K (2007) Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. J Clin Pharm Ther 32:333\u2013341","journal-title":"J Clin Pharm Ther"},{"key":"2061_CR14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.0306-5251.2001.01499.x","volume":"52","author":"JA Goldstein","year":"2001","unstructured":"Goldstein JA (2001) Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol 52:349\u2013355","journal-title":"Br J Clin Pharmacol"},{"key":"2061_CR15","unstructured":"Diazepam, Pharmacogenomic information. http:\/\/www.fda.gov\/drugs\/scienceresearch\/researchareas\/pharmacogenetics\/ucm236311.htm . Accessed 30 Nov 2015"},{"key":"2061_CR16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clpt.2005.08.020","volume":"78","author":"S Inomata","year":"2005","unstructured":"Inomata S, Nagashima A, Itagaki F et al (2005) CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia. Clin Pharmacol Ther 78:647\u2013655","journal-title":"Clin Pharmacol Ther"},{"key":"2061_CR17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/clpt.1989.40","volume":"45","author":"L Bertilsson","year":"1989","unstructured":"Bertilsson L, Henthorn TK, Sanz E et al (1989) Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clin Pharmacol Ther 45:348\u2013355","journal-title":"Clin Pharmacol Ther"},{"key":"2061_CR18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1996.tb00010.x","volume":"42","author":"J Wan","year":"1996","unstructured":"Wan J, Xia H, He N et al (1996) The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype. Br J Clin Pharmacol 42:471\u2013474","journal-title":"Br J Clin Pharmacol"},{"key":"2061_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00228-006-0105-3","volume":"62","author":"N Rais","year":"2006","unstructured":"Rais N, Chawla YK, Kohli KK (2006) CYP3A phenotypes and genotypes in North Indians. Eur J Clin Pharmacol 62:417\u2013422","journal-title":"Eur J Clin Pharmacol"},{"key":"2061_CR20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.etap.2009.12.001","volume":"29","author":"V Kumar","year":"2010","unstructured":"Kumar V, Singh S, Yadav CS et al (2010) CYP1A1 and CYP3A4 polymorphic variations in Delhi population of Northern India. Environ Toxicol Pharmacol 29:126\u2013130","journal-title":"Environ Toxicol Pharmacol"},{"key":"2061_CR21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.etap.2014.03.013","volume":"37","author":"S Gulati","year":"2014","unstructured":"Gulati S, Yadav A, Kumar N et al (2014) Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population. Environ Toxicol Pharmacol 37:1186\u20131193","journal-title":"Environ Toxicol Pharmacol"},{"key":"2061_CR22","unstructured":"CYP2C19 - cytochrome P450, family 2, subfamily C, polypeptide 19 (2014). In: Genet. Home Ref. http:\/\/ghr.nlm.nih.gov\/gene\/CYP2C19 . Accessed 5 Aug 2014"},{"key":"2061_CR23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2125.2003.01883.x","volume":"56","author":"C Adithan","year":"2003","unstructured":"Adithan C, Gerard N, Vasu S et al (2003) Allele and genotype frequency of CYP2C19 in a Tamilian population. Br J Clin Pharmacol 56:331\u2013333","journal-title":"Br J Clin Pharmacol"},{"key":"2061_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2710.2011.01294.x","volume":"37","author":"D Anichavezhi","year":"2012","unstructured":"Anichavezhi D, Chakradhara Rao US, Shewade DG et al (2012) Distribution of CYP2C19*17 allele and genotypes in an Indian population. J Clin Pharm Ther 37:313\u2013318","journal-title":"J Clin Pharm Ther"},{"key":"2061_CR25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/clpt.1983.256","volume":"34","author":"EM Sellers","year":"1983","unstructured":"Sellers EM, Naranjo CA, Harrison M, Devenyi P, Roach C, Sykora K (1983) Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 34:822\u2013826","journal-title":"Clin Pharmacol Ther"},{"key":"2061_CR26","first-page":"170","volume":"98","author":"S Manikant","year":"1993","unstructured":"Manikant S, Tripathi BM, Chavan BS (1993) Loading dose diazepam therapy for alcohol withdrawal state. Indian J Med Res 98:170\u2013173","journal-title":"Indian J Med Res"},{"key":"2061_CR27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/cp.1999.v66.103379001","volume":"66","author":"XP Qin","year":"1999","unstructured":"Qin XP, Xie HG, Wang W et al (1999) Effect of the gene dosage of CYP2C19 on diazepam metabolism in Chinese subjects. Clin Pharmacol Ther 66:642\u2013646","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"2061_CR28","first-page":"S123","volume":"23","author":"D Jacques","year":"2011","unstructured":"Jacques D, Zdanowicz N, Reynaert C et al (2011) Intensity of symptoms from alcohol withdrawal in alcohol-dependent patients: comparison between smokers and non-smokers. Psychiatr Danub 23(Suppl 1):S123\u2013125","journal-title":"Psychiatr Danub"},{"key":"2061_CR29","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.3748\/wjg.14.5197","volume":"14","author":"M Sugimoto","year":"2008","unstructured":"Sugimoto M, Furuta T, Nakamura A et al (2008) Maintenance time of sedative effects after an intravenous infusion of diazepam: a guide for endoscopy using diazepam. World J Gastroenterol WJG 14:5197\u20135203","journal-title":"World J Gastroenterol WJG"},{"key":"2061_CR30","first-page":"1284","volume":"29","author":"K Kosuge","year":"2001","unstructured":"Kosuge K, Jun Y, Watanabe H et al (2001) Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status. Drug Metab Dispos Biol Fate Chem 29:1284\u20131289","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"2061_CR31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3565(25)33060-0","volume":"221","author":"LM Aaronson","year":"1982","unstructured":"Aaronson LM, Hinman DJ, Okamoto M (1982) Effects of diazepam on ethanol withdrawal. J Pharmacol Exp Ther 221:319\u2013325","journal-title":"J Pharmacol Exp Ther"},{"key":"2061_CR32","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/archinte.1997.00440400084010","volume":"157","author":"KL Kraemer","year":"1997","unstructured":"Kraemer KL, Mayo-Smith MF, Calkins DR (1997) Impact of age on the severity, course, and complications of alcohol withdrawal. Arch Intern Med 157:2234\u20132241","journal-title":"Arch Intern Med"},{"key":"2061_CR33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1360-0443.1995.tb03551.x","volume":"90","author":"MA Schuckit","year":"1995","unstructured":"Schuckit MA, Tipp JE, Reich T, Hesselbrock VM, Bucholz KK (1995) The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction 90:1335\u20131347","journal-title":"Addiction"},{"key":"2061_CR34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/10550490600625798","volume":"15","author":"T Wright","year":"2006","unstructured":"Wright T, Myrick H, Henderson S, Peters H, Malcolm R (2006) Risk factors for delirium tremens: a retrospective chart review. Am J Addict 15:213\u2013219","journal-title":"Am J Addict"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2061-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2061-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T20:33:28Z","timestamp":1748896408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2061-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,20]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2061-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,20]]}}}